Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer

NCT04792515 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
67
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

First Affiliated Hospital Xi'an Jiaotong University

Collaborators